Oxford Molecular, Hoffmann-La Roche, Abbott deal

OMG licensed to both pharma companies the chemical analytical applications of RS3 Discovery, a software program that transforms relational database systems into a chemical-structure search engine based on the Oracle database platform. The licenses are the first commercial installations of RS3 Discovery, OMG said.

The Roche agreement covers applications of RS3 Discovery to integrate the analysis of chemical structures with other corporate data. ...